TickerFactsScreenerDevelopers

Black Diamond Therapeutics, Inc. (BDTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$6.67M2018: -$15.54M2019: -$47.16M2020: $307.76M2021: $195.90M2022: $115.69M2023: $116.74M2024: $83.28M2025: $112.21M$112.21M
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$112.21M+34.7%
2024$83.28M-28.7%
2023$116.74M+0.9%
2022$115.69M-40.9%
2021$195.90M-36.3%
2020$307.76M+752.6%
2019-$47.16M-203.4%
2018-$15.54M-132.8%
2017-$6.67M—